MedPath

北京韩美生物科技有限公司

Ownership
-
Established
2022-02-25
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

3

NMPA:3

Drug Approvals

Levocetirizine Dihydrochloride Oral Solution

Product Name
盐酸左西替利嗪口服溶液
Approval Number
国药准字H20254395
Approval Date
May 27, 2025
NMPA

Lactulose Oral Solution

Product Name
乳果糖口服溶液
Approval Number
国药准字H20254035
Approval Date
Apr 30, 2025
NMPA

Lactulose Oral Solution

Product Name
乳果糖口服溶液
Approval Number
国药准字H20253514
Approval Date
Mar 4, 2025
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.